SG
Srikanth Gubba
About Srikanth Gubba
Data last updated:
Srikanth Gubba is a Director at Hindava Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Hindava Pharmaceuticals Private Limited reported revenue of ₹51.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hindava Pharmaceuticals Private Limited U21001TS2023PTC175326 | Director | 24 Jul 2023 | 2023 | ₹51.2 Lakh (FY 2025) | Active |
Board colleagues of Srikanth Gubba
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ravindar Reddy Vemula | 10252330 | Hindava Pharmaceuticals Private Limited | Director |
| Swetha Nemili | 10252332 | Hindava Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srikanth Gubba
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srikanth Gubba
Srikanth Gubba currently holds 1 directorship: Hindava Pharmaceuticals Private Limited (Director, since 24 Jul 2023, revenue ₹51.2 Lakh (FY 2025)).
Srikanth Gubba was first appointed on 24 Jul 2023 as Director at Hindava Pharmaceuticals Private Limited.
The current boards of Srikanth Gubba's companies include Ravindar Reddy Vemula (Hindava Pharmaceuticals Private Limited), Swetha Nemili (Hindava Pharmaceuticals Private Limited).